 |
市場調查報告書
商品編碼
2148352
抗體片段市場：按類型、來源、應用、最終用戶和地區分類Antibody Fragments Market, By Type, By Source, By Application, By End User, By Geography |
||||||
價格
簡介目錄
預計到2026年，抗體片段市場規模將達到85.8億美元，到2033年將達到128.9億美元。預計從2026年到2033年，其複合年成長率將達到6.0%。
| 報告範圍 | 報告詳情 | ||
|---|---|---|---|
| 基準年： | 2025 | 2026年市場規模： | 85.8億美元 |
| 歷史數據時期： | 2020年至2024年 | 預測期： | 2026年至2033年 |
| 2026年至2033年預測期間的複合年成長率： | 6.00% | 2033年市場規模預測： | 128.9億美元 |
抗體片段是完整抗體的工程化或天然組成部分，它們保留了抗原辨識能力，同時具有體積小、組織滲透性高、免疫抗原性低等優點。主要類型的抗體片段包括Fab、F(ab')2、scFv、奈米抗體和雙抗體，它們透過酶解或重組技術生產，用於治療、診斷、藥物遞送和分子成像等領域。
全球抗體片段市場的發展主要受生物製藥研究的蓬勃發展、慢性病和自體免疫疾病負擔的加重以及生物製藥療法的廣泛應用所驅動。基於噬菌體展示、酵母展示和CRISPR等技術的抗體工程創新，正在拓展抗體片段的設計和生產能力，使其成為下一代精準醫療和標靶治療的關鍵組成部分。
市場動態
全球抗體片段市場的發展主要受以下因素驅動：癌症和自體免疫疾病負擔日益加重、對標靶生技藥品的需求不斷成長，以及噬菌體展示、核醣體展示和電腦輔助設計等抗體工程技術的進步。此外，基於片段的雙特異性抗體、抗體藥物複合體物 (ADC) 和其他新一代生技藥品的開發，正在加速相關研究、研發和商業性應用。
然而，抗體片段市場的成長受到許多因素的限制，例如血清半衰期短、生產流程複雜、研發成本高、法規要求嚴格。儘管如此，在新興市場藥物研發和合作研究不斷拓展的推動下，奈米抗體和基於片段的分子成像、標靶藥物遞送以及抗體工程外包等領域仍蘊藏著巨大的商機。
本次調查的主要特點
- 本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
- 此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
- 本研究根據以下參數介紹了全球抗體片段市場主要參與者的概況：公司概況、產品系列、主要亮點、財務績效和策略。
- 本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
- 這份全球抗體片段市場報告的目標受群眾外包括產業內的各種相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
- 相關人員可以透過分析全球抗體片段市場中使用的各種策略矩陣來簡化決策過程。
目錄
第1章：研究目標與前提條件
- 分析目的
- 先決條件
- 簡稱
第2章 市場展望
- 報告說明
- 市場定義和範圍
- 執行摘要
第3章：市場動態、監管與趨勢分析
- 市場動態
- 影響分析
- 主要亮點
- 監管趨勢
- 產品上市及核准
- PEST分析
- 波特的分析
- 市場機遇
- 監管趨勢
- 產業趨勢
第4章 全球抗體片段市場：依類型分類，2021-2033年
- Fab/Fab'片段
- F(ab')2片段
- scFv
- 單域抗體/奈米抗體/VHH
- 雙特異性和多特異性抗體片段
- 其他
第5章 全球抗體片段市場：依來源分類，2021-2033年
- 人源化/重組
- 動物源性/多克隆抗體
- 合成的/庫衍生的/預先設計的
第6章 全球抗體片段市場：依應用領域分類，2021-2033年
- 治療
- 診斷和影像
- 研究試劑
- 藥物遞送和偶聯物
- 生物感測器
- 其他
第7章 全球抗體片段市場：依最終用戶分類，2021-2033年
- 製藥和生物技術公司
- 診斷檢查室
- 學術研究機構
- CRO／CDMO
- 其他
第8章 全球抗體片段市場：依地區分類，2021-2033年
- 北美洲
- 美國
- 加拿大
- 拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
- 歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
- 亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太國家
- 中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
- 非洲
- 南非
- 北非
- 中非
第9章 競爭情勢
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Danaher Corporation
- Bio-Rad Laboratories, Inc.
- Bio-Techne Corporation
- Creative Biolabs Inc.
- Jackson ImmunoResearch Inc.
- Rockland Immunochemicals, Inc.
- SouthernBiotech, Inc.
- Absolute Antibody Ltd.
第10章 分析師建議
- 機會分析
- 分析師意見
- Coherent Opportunity Map
第11章 參考文獻與調查方法
- 參考
- 調查方法
- 關於本公司
簡介目錄
Product Code: CMI10040
Antibody Fragments Market is estimated to be valued at USD 8.58 Bn in 2026 and is expected to reach USD 12.89 Bn by 2033, growing at a compound annual growth rate (CAGR) of 6.0% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 8.58 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 6.00% | 2033 Value Projection: | USD 12.89 Bn |
Antibody fragments are designed or naturally occurring parts of complete antibodies that retain antigen recognition capacity but provide advantages including smaller size, increased tissue penetration and decreased immunogenicity. The major types of fragments are Fab, F(ab') 2, scFv, nanobodies and diabodies, which are produced by enzymatic digestion or recombinant techniques for therapeutic, diagnostic, drug-delivery and molecular-imaging purposes.
The global antibody fragments market is driven by a surge in biopharmaceutical research, increasing burden of chronic and autoimmune diseases, and rising use of biologic therapies. Innovations in phage display, yeast display, and CRISPR-based antibody engineering are expanding the design and production capabilities of fragments, making antibody fragments a key element in next-generation precision medicine and targeted treatments.
Market Dynamics
The global antibody fragments market is driven by the increasing burden of cancer and autoimmune diseases, growing demand for targeted biologics, and technological advancements in antibody engineering methods such as phage display, ribosome display, and computational design. Further research and commercial adoption are boosted by the development of fragment-based bispecific, ADCs, and other next-generation biologics.
However, the growth of antibody fragments market is limited by factors such as shorter serum half-life, complex manufacturing, high development cost and stringent regulatory requirement. Nevertheless, significant opportunities exist in nanobodies, fragment-based molecular imaging, targeted drug delivery and outsourced antibody engineering, supported by the growing pharmaceutical R&D and collaborations across the emerging markets.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global antibody fragments market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Merck KGaA, Danaher Corporation, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Creative Biolabs Inc., Jackson ImmunoResearch Inc., Rockland Immunochemicals, Inc., SouthernBiotech, Inc., and Absolute Antibody Ltd.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global antibody fragments market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global antibody fragments market
Market Segmentation
- Type Insights (Revenue, USD Bn, 2021 - 2033)
- Fab / Fab' Fragments
- F(ab')2 Fragments
- scFv
- sdAb / Nanobodies / VHH
- Bispecific and Multispecific Antibody Fragments
- Others
- Source Insights (Revenue, USD Bn, 2021 - 2033)
- Humanized / Recombinant
- Animal-derived / Polyclonal
- Synthetic / Library-derived / Engineered
- Application Insights (Revenue, USD Bn, 2021 - 2033)
- Therapeutics
- Diagnostics and Imaging
- Research Reagents
- Drug Delivery and Conjugates
- Biosensors
- Others
- End User Insights (Revenue, USD Bn, 2021 - 2033)
- Pharmaceutical and Biotechnology Companies
- Diagnostic Laboratories
- Academic and Research Institutes
- CROs/CDMOs
- Others
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Danaher Corporation
- Bio-Rad Laboratories, Inc.
- Bio-Techne Corporation
- Creative Biolabs Inc.
- Jackson ImmunoResearch Inc.
- Rockland Immunochemicals, Inc.
- SouthernBiotech, Inc.
- Absolute Antibody Ltd.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Antibody Fragments Market, By Type
- Global Antibody Fragments Market, By Source
- Global Antibody Fragments Market, By Application
- Global Antibody Fragments Market, By End User
- Global Antibody Fragments Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Market Opportunities
- Regulatory Scenario
- Industry Trends
4. Global Antibody Fragments Market, By Type, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Fab / Fab' Fragments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- F(ab')2 Fragments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- scFv
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- sdAb / Nanobodies / VHH
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Bispecific and Multispecific Antibody Fragments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
5. Global Antibody Fragments Market, By Source, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Humanized / Recombinant
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Animal-derived / Polyclonal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Synthetic / Library-derived / Engineered
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
6. Global Antibody Fragments Market, By Application, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Therapeutics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Diagnostics and Imaging
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Research Reagents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Drug Delivery and Conjugates
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Biosensors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
7. Global Antibody Fragments Market, By End User, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Pharmaceutical and Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- CROs/CDMOs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
8. Global Antibody Fragments Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
9. Competitive Landscape
- Thermo Fisher Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck KGaA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Danaher Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bio-Rad Laboratories, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bio-Techne Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Creative Biolabs Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Jackson ImmunoResearch Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Rockland Immunochemicals, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- SouthernBiotech, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Absolute Antibody Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
10. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. References and Research Methodology
- References
- Research Methodology
- About us
02-2729-4219
+886-2-2729-4219
